Revival Plus, 20 mg + 12.5 mg, film-coated tablets
Revival Plus, 20 mg + 25 mg, film-coated tablets
Olmesartan medoxomil + Hydrochlorothiazide
Revival Plus contains two active substances, olmesartan medoxomil and hydrochlorothiazide, which are used to treat high blood pressure (hypertension).
Revival Plus is used to treat high blood pressure in patients whose blood pressure is not adequately controlled by taking olmesartan medoxomil (Revival) alone. The combination of the two active substances in Revival Plus has been shown to be more effective at lowering blood pressure than taking either substance alone.
Do not take the tablets if any of the above applies to you, or if you are not sure. Consult your doctor and follow their advice.
Before taking Revival Plus, discuss it with your doctor.
Tell your doctorif you are taking any of the following medicines used to treat high blood pressure:
Your doctor may recommend regular checks of your kidney function, blood pressure, and electrolyte levels (e.g., potassium).
See also the section "When not to take Revival Plus".
Tell your doctorif you have any of the following conditions:
Tell your doctorif you experience any of the following symptoms:
If you experience any of the above conditions, your doctor may recommend more frequent visits and certain tests.
Revival Plus is not recommended for children and adolescents under 18 years of age.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take, especially:
Revival Plus can be taken with or without food.
Be cautious when drinking alcohol while taking Revival Plus, as it may cause dizziness or fainting in some people. If you experience these symptoms, do not consume any alcohol, including wine, beer, or cocktails.
As with other medicines in this class, the blood pressure-lowering effect of Revival Plus is weaker in black patients.
Tell your doctor if you are pregnant or planning to become pregnant. Your doctor will usually recommend stopping Revival Plus before a planned pregnancy or as soon as you know you are pregnant, and will recommend an alternative medicine. Revival Plus should not be taken during early pregnancy and must not be taken after the third month of pregnancy, as it may harm the baby (see section "Pregnancy and breastfeeding").
Tell your doctor if you are breastfeeding or planning to breastfeed. Revival Plus is not recommended during breastfeeding. Your doctor may recommend an alternative medicine during breastfeeding.
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
During treatment for high blood pressure, you may experience drowsiness or dizziness.
Do not drive or operate machinery until these symptoms have resolved.
Consult your doctor for advice.
This medicine contains lactose (a type of sugar). If you have been told that you have an intolerance to some sugars, contact your doctor before taking this medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
Recommended doseis one Revival Plus 20 mg + 12.5 mg tablet per day. If this dose does not provide adequate blood pressure control, your doctor may increase the dose to one Revival Plus 20 mg + 25 mg tablet per day.
Swallow the tablet with water. If possible, take your daily dose at the same timeevery day, for example, at breakfast time. It is important to continue taking Revival Plus unless your doctor tells you to stop.
If you take more Revival Plus than you should or if a child accidentally swallows some, contact your doctor or the nearest hospital emergency department immediately, taking the medicine pack with you.
If you forget to take a dose, take the next dose at the usual time. Do nottake a double dose to make up for a forgotten dose.
It is important to continue taking Revival Plus unless your doctor tells you to stop.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Revival Plus can cause side effects, although not everybody gets them.
However, the following serious side effects may occur:
Revival Plus is a combination medicine. The following information is about side effects that have been reported with Revival Plus (in addition to those listed above) and with the individual active substances.
If you experience the following side effects, they are usually mild and do not require stopping treatment.
Dizziness, weakness, headache, fatigue, chest pain, swelling of the ankles, feet, legs, hands, or arms.
Palpitations (awareness of heartbeat), rash, itching, dizziness, cough, nausea, vomiting, diarrhea, muscle cramps and pain, back pain, joint pain, pain in the arms and legs, elevated lipid levels in the blood, elevated uric acid levels in the blood, elevated creatinine levels in the blood, elevated or decreased potassium levels in the blood, elevated calcium levels in the blood, elevated blood sugar levels, elevated liver enzyme activity.
Malaise, changes in consciousness, skin eruptions (blisters), acute kidney failure.
Rarely, changes in blood test results, including elevated urea levels in the blood, decreased hemoglobin and hematocrit values, have been observed.
Bronchitis, cough, runny nose or stuffy nose, sore throat, abdominal pain, nausea, diarrhea, gastroenteritis, back pain, blood in the urine, urinary tract infection, flu-like symptoms, pain.
Anaphylactic reaction (a severe, potentially life-threatening allergic reaction), angioedema (swelling of the face, lips, tongue, or throat), chest pain (angina pectoris), malaise, allergic skin rash, itching, urticaria (hives), guzki na skórze (bąble).
Kidney problems, lack of energy; intestinal angioedema: swelling in the intestine with symptoms such as abdominal pain, nausea, vomiting, and diarrhea.
Rarely, changes in blood test results, including elevated potassium levels in the blood, have been observed.
Changes in blood test results, including elevated lipid and uric acid levels in the blood.
Disorientation, abdominal pain, nausea, vomiting, constipation, elevated creatinine levels in the blood, elevated urea levels in the blood, elevated calcium levels in the blood, decreased chloride, potassium, magnesium, and sodium levels in the blood, elevated amylase levels (hyperamylasemia).
Loss of appetite, severe breathing difficulties, skin allergic reaction (hypersensitivity reactions), worsening of existing myopia, rash, photosensitivity reactions, itching, purpura (purple spots on the skin due to small blood vessel bleeding), guzki na skórze (bąble).
Painful swelling of the salivary glands; decreased white blood cell count; decreased platelet count; anemia; bone marrow damage; anxiety; depression; sleep disturbances; apathy; tingling or numbness; seizures; yellow vision; blurred vision; dry eye; heart rhythm disturbances; vasculitis (inflammation of blood vessels); blood clots (thrombosis or embolism); pneumonia; fluid accumulation in the lungs; pancreatitis; jaundice; gallbladder inflammation; symptoms of lupus, such as rash, joint pain, and Raynaud's phenomenon; allergic skin reactions; skin peeling and blistering; non-infectious kidney inflammation (interstitial nephritis); fever; muscle weakness (sometimes causing movement disorders).
Electrolyte disturbances leading to abnormal low levels of chloride in the blood (hypochloremic alkalosis), paralytic ileus (paralysis of the intestinal muscles).
Acute respiratory failure (symptoms include severe shortness of breath, fever, weakness, and confusion).
Blurred vision or eye pain due to increased pressure (possible symptoms of fluid accumulation in the vascular layer surrounding the eye - excessive fluid accumulation between the choroid and sclera - or acute angle-closure glaucoma).
Malignant tumors of the skin and lips (non-melanoma skin cancer).
If you experience any side effects, including any not listed in this leaflet, tell your doctor or pharmacist, or nurse.
Side effects can be reported directly to the Pharmacovigilance Department, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw
Phone: (22) 49-21-301
Fax: (22) 49-21-309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
This medicine does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the carton after EXP. The expiry date refers to the last day of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
The active substances are olmesartan medoxomil and hydrochlorothiazide.
Revival Plus 20 mg + 12.5 mg: Each film-coated tablet contains 20 mg of olmesartan medoxomil and 12.5 mg of hydrochlorothiazide.
Revival Plus 20 mg + 25 mg: Each film-coated tablet contains 20 mg of olmesartan medoxomil and 25 mg of hydrochlorothiazide.
Other ingredients are microcrystalline cellulose, hypromellose, lactose monohydrate*, hypromellose, magnesium stearate, hypromellose, talc, titanium dioxide, yellow iron oxide (E 172), red iron oxide (E 172).
* See section "Revival Plus contains lactose" above.
Revival Plus 20 mg + 12.5 mg: Reddish-yellow, round, film-coated tablets, 8.5 mm in diameter, with "C 22" engraved on one side.
Revival Plus 20 mg + 25 mg: Pink, round, film-coated tablets, 8.5 mm in diameter, with "C 24" engraved on one side.
Revival Plus is available in packs of 14, 28, 56, or 98 film-coated tablets, and in packs of 10, 50, and 500 film-coated tablets in perforated blisters.
Marketing authorization holder
Menarini International Operations Luxembourg S.A.
1, Avenue de la Gare
L-1611 Luxembourg
Luxembourg
Manufacturer
Daiichi Sankyo Europe GmbH
Luitpoldstrasse 1
85276 Pfaffenhofen, Ilm, Germany
Berlin-Chemie AG
Glienicker Weg 125
12489 Berlin, Germany
Menarini Von Heyden GmbH
Leipziger Str. 7-13
01097 Dresden
Germany
Only for hospital use packaging
Qualiphar N.V.
Rijksweg 9
2880 Bornem, Belgium
For further information, contact the marketing authorization holder's representative:
Austria: Mencord Plus
Belgium: Belsar Plus
Cyprus: Olartan Plus
Czech Republic: Sarten Plus H
Germany: Votum Plus
Greece: Olartan Plus
Estonia: Mesar Plus
France: Alteisduo
Hungary: Laresin Plus
Ireland: Omesar Plus
Italy: Olprezide
Lithuania: Mesar Plus
Luxembourg: Belsar Plus
Latvia: Mesar Plus
Malta: Omesar Plus
Poland: Revival Plus
Portugal: Olsar Plus
Spain: Ixia Plus
Slovenia: Co-Tensiol
Slovakia: Tenzar Plus
Date of last revision of the leaflet:01/2025
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.